Basic aspects of vasorelaxant and bronchodilating peptides in clinical use: urodilatin (INN: Ularitide), VIP, and PACAP.
Meyer
M
M
Niedersächsisches Institut für Peptid-Forschung (IPF), Hannover, Germany.
Flüge
T
T
Kruhøffer
M
M
Forssmann
W G
WG
D058186:Acute Kidney Injury / Q000188:drug therapy*; D000595:Amino Acid Sequence; D000818:Animals; D001249:Asthma / Q000188:drug therapy*; D009320:Atrial Natriuretic Factor / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008168:Lung / Q000187:drug effects / Q000502:physiology / Q000503:physiopathology; D008969:Molecular Sequence Data; D009479:Neuropeptides / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D010446:Peptide Fragments / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D014660:Vasoactive Intestinal Peptide / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*
C495401:ADCYAP1 protein, human; D001993:Bronchodilator Agents; D009479:Neuropeptides; D010446:Peptide Fragments; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D014665:Vasodilator Agents; D014660:Vasoactive Intestinal Peptide; C056452:Ularitide; D009320:Atrial Natriuretic Factor